Tagged with M

family business Adrian Fernandez, current CEO, shares his experience of taking a domestic company international and the viability of the family business model in the contemporary market.   As a rapidly internationalizing company, how much of a burden have regulatory barriers between countries placed on your business? Its not too much of…

medical tourism Malaysia Healthcare Travel Council’s CEO is proud of her country’s healthcare system and their efforts at attracting medical tourists from all over the world, with the support of the healthcare NKEA and the government’s efforts to become a reference in healthcare worldwide.     Medical tourism has been a national…

pain management Mundipharma Malaysia’s country manager discusses his company’s aim to become a reference in Malaysia for pain management, on the back of the tremendous 48 percent growth of the business last year.    Mundipharma has recently entered a booming Malaysian pharmaceutical sector. What are your first impressions of the Malaysian market? Malaysia’s pharmaceutical sector…

CNS Lundbeck’s country manager gives a thorough overview of CNS disorders in Malaysia and states: “It is important to remind everyone that mental health conditions or brain diseases are not to be overlooked.” While this is a challenge, it also represents an opportunity for Lundbeck to provide best-in-line products to patients.…

insulin The president of Denver Farma explains how crucial exports are for his company, especially to countries like Brazil where the market participation of local companies is small, and multinational companies large: exactly the opposite of the Argentinian model.   In 2002, the former minister of health, Gines Gonzalez, created the generics…

Pfizer Edgardo Vázquez, Pfizer’s country manager for the Argentina Region, discusses the company’s investment strategies across their newly established business units and a few of the unique challenges presented by the Argentinean market.   How have Pfizer’s goals for Argentina changed over the last few years, and what is your strategy…

medical devices The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers.   Why did Lexel enter into the medical device market and most important, where did you see the opportunities when creating this company? From the…

regulation Carlos Chiale, National Administrator of ANMAT, discusses the agency’s latest strategy implementation and its pioneering work in the area of fighting drug falsification.   Could you provide a historical overview of ANMAT, its main achievements and current activities today? Since its creation in 1992, ANMAT has performed activities intended for…

doctors MMA’s president shares the reasons why Malaysia is ranked today third in terms of healthcare quality, with a very efficient public system, high quality doctors and strong government support. However, the situation could change as too many doctors change to the private sector, NCDs are drastically increasing and financing healthcare…

IMS IMS in Malaysia is possibly the first company to have signed a Memorandum of Understanding with the government for data provision. IMS Health’s general manager introduces this landmark and also shares the opportunities present for pharma companies to invest in Malaysia.     IMS is now providing data for the…

similars The vice president of Laboratorios Beta discusses the factors of why his organization is on the  way to consolidating its different business lines and becoming a pure pharmaceutical company.     2014 marks the 74th anniversary of Laboratorios Beta. To what extent is the company today still the same company…

chamber of commerce MGCC’s Executive Director discusses the opportunities and challenges for German pharma and healthcare companies to invest in Malaysia, at a time where most have decided to invest and base their headquarters in Singapore.     Could you please start by introducing what are the main tasks and objectives of the…